Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Acurx Pharmaceuticals LLC

Current price
2.25 USD -0.13 USD (-5.46%)
Last closed 2.38 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 35 646 976 USD
Yield for 12 month -16.36 %
21.11.2021 - 28.11.2021

Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York. Address: 259 Liberty Avenue, Staten Island, NY, United States, 10305

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
MSFT MSFT Microsoft


WallStreet Target Price

11.66 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures ACXP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Operating Margin TTM
PE Ratio
Return On Assets TTM -121.65 %
PEG Ratio
Return On Equity TTM -283.87 %
Wall Street Target Price 11.66 USD
Revenue TTM
Book Value 0.38 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -1.18 USD
Diluted Eps TTM -1.18 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ACXP

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ACXP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation ACXP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -1.4113
Price Book MRQ 0.4845

Financials ACXP

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ACXP

For 52 weeks

1.17 USD 8.82 USD
50 Day MA 2.21 USD
Shares Short Prior Month 595 642
200 Day MA 2.96 USD
Short Ratio 8.63
Shares Short 688 377
Short Percent 4.43 %

Dynamics of changes in the value of assets




446.34 USD Microsoft Corporation -3.37 (-0.75%)
Detailed analytics

ETF funds



203.95 CHF UBS SLI A-dis -0.06 (-0.02%)
Detailed analytics



2339.94 USD Gold +11.09 (+0.48%)
Detailed analytics